USPTF

In the 1990’s USA: PSA Screening Reduced Instances of Initial Diagnosis of Metastatic Prostate Cancer By 50%

Screening for early cancer detection may reduce the rate of related metastatic disease, but not always. In a published study in the New England Journal of Medicine, researchers evaluated the incidence of men having a diagnosis of advanced, metastatic prostate cancer at the initial prostate cancer diagnosis. The researchers data from the Surveillance, Epidemiology, and [...]

By Malecare|2017-10-19T10:45:58-04:00December 4th, 2016|Advanced Prostate Cancer, Advocacy, Biomarkers and Prognostic Tools, Uncategorized, USPTF|0 Comments

Of Interest In the News – Surprise Out-of Network Bills and the U.S. Preventive Task Force Becomes Controversial

In an article in Time (3/7 Sweetland Edwards) there is a discussion about the failure of the Affordable Care Act to stop patients from receiving “surprise” bills from their medical providers for services provided. These surprises result from people going to a medical facility, which is in their Network but having some service, provided by [...]

By Malecare|2020-02-04T12:41:14-05:00March 9th, 2016|Advanced Prostate Cancer, Insurance, Politics of Cancer, Uncategorized, USPTF|